NCT04693559
Assessment of Nanocrystalline Hydroxyapatite Versus Autogenous Bone Grafts : A Comparative Clinical Study in Alveolar Cleft Grafting
Assiut University·ClinicalTrials.gov·procedureNot yet recruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Alveolar Cleft
- Drug/Device/Intervention
- secondary alveolar bone graft
- Study type
- Interventional
- Intervention type
- procedure
Sponsor & location
- Primary sponsor
- Assiut University
Timeline & enrollment
- Phase
- N/A
- Start date
- Jan 01, 2021
- End date
- Mar 01, 2023
- Enrollment
- 20 participants
Primary outcome
Measuring of bone volume 6 months post-operative
Summary
This work aims to evaluate Nanocrystalline Hydroxyapatite versus Autogenous bone grafts in
 alveolar cleft grafting
ICD-10 classifications
Cleft palateCleft palate, unspecifiedCleft soft palateOther branchial cleft malformationsCleft uvula
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04693559
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT04693559 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Alveolar Cleft. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.